Skip to main content
Pharmsville Co., Ltd. logo

Pharmsville Co., Ltd. — Investor Relations & Filings

Ticker · 318010 ISIN · KR7318010006 KO Manufacturing
Open in API
Filings indexed 129 across all filing types
Latest filing 2020-05-08 Earnings Release
Country KR South Korea
Listing KO 318010

About Pharmsville Co., Ltd.

http://pharmsville.net/

Pharmsville Co., Ltd. is a bio-healthcare company that develops, produces, and sells health functional foods and natural supplements. Founded in 2000, the company focuses on extending human healthspan through the research and development of novel ingredients, with a specialization in microbiome-based probiotics. Its product portfolio is marketed to both domestic and international consumers under brands such as 'Appletree Dr.'. The company supports its innovation through dedicated research facilities, including the Pharmsville Bio Lab, aiming to create health products that are as natural as possible for the human body.

Recent filings

Filing Released Lang Actions
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for the company 'Pharmsville' (팜스빌) for the first quarter of 2020. It provides key financial highlights such as revenue, operating profit, and net income, comparing them to previous periods. This fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results. Q1 2020
2020-05-08 Korean
사업보고서 (2019.12)
Annual Report Classification · 100% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for the company 'Pharmsville' (주식회사 팜스빌) for the fiscal year ending December 31, 2019. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. This constitutes a full annual financial report, which falls under the '10-K' category in the provided schema. FY 2019
2020-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend declarations, and director appointments. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2020-03-27 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Pharmsville, specifically detailing a decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). This is a corporate action related to share buybacks. According to the provided definitions, 'Transaction in Own Shares' (POS) is the correct category for reports regarding a company buying back its own shares.
2020-03-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by major shareholders and their special relations (insiders/family members) through market purchases. This document type is specifically used to notify the market of significant changes in share ownership (crossing thresholds), which aligns with the 'Major Shareholding Notification' category.
2020-03-24 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from the company '팜스빌'. It provides a summary of the audit opinion (which is '적정' or 'unqualified') and key financial data (assets, liabilities, revenue, profit) for the current and previous fiscal years. According to the 'Menu vs Meal' rule, this is a short announcement summarizing the audit results and confirming the submission of the audit report to the regulatory body, rather than the full, lengthy audit report document itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2019
2020-03-19 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.